• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE INTERCEED 5INX6IN; BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE INTERCEED 5INX6IN; BARRIER, ABSORBABLE, ADHESION Back to Search Results
Catalog Number 4350XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Obstruction/Occlusion (2422)
Event Type  Injury  
Event Description
It was reported that a patient underwent a laparoscopic colon resection procedure on an unknown date and an absorbable adhesion barrier was used.The patient was discharged 10 days after surgery, however, one week after the discharge, the patient was readmitted to the hospital because of poor food passage.Then, reoperation was performed due to suspected bowel obstruction.There was a bowel obstruction.It was attached/had adhesions only where the adhesion barrier was used.(the ochre color of the adhesion barrier could be seen around the incision wound.) it seems that probably the adhesion barrier caused some biological reaction and because of that, the intestine stuck together.The patient was already discharged from the hospital and returned to society.The surgeon said, ¿i have had similar experiences with other anti-adhesion materials, but i felt that the anti-adhesion materials may have reacted to the anti-adhesion materials and pulled them in the opposite direction.I think that anti-adhesion material is necessary in open cases, but i feel that it is unnecessary in laparoscopic surgery because the skin incision is small.¿ additional information has been requested.
 
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure date of index surgical procedure? the diagnosis and indication for the index surgical procedure? were any concomitant procedures performed? what symptoms did the patient experience following the index surgical procedure? onset date? other relevant patient history/concomitant medications? were pre-existing adhesions noted during the procedure? how were the post-procedural adhesions confirmed? what is the location and severity of the adhesions? please describe any surgical intervention required including the date and results.Was meticulous hemostasis performed prior to use of product? what color was the interceed prior to closure? did the interceed come in contact with heme prior to use? how was the product applied? one layer? wadded? what suture was used to close the incision? was there excessive tissue desiccation (cautery use) at the site of interceed application? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status? product lot number? to date it has been reported that the device will not be returned.If the device or further details are received at a later date a supplemental medwatch will be sent.H6 component code: g07002 ¿ device not returned.
 
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested and the following response was received: please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedureunk.Date of index surgical procedure?:laparoscopic colorectomy the diagnosis and indication for the index surgical procedure?:unk.Were any concomitant procedures performed?: no.What symptoms did the patient experience following the index surgical procedure?: onset date?: one week after the discharge, the patient was readmitted to the hospital because of poor food passage.Then, reoperation was performed due to suspected bowel obstruction.Other relevant patient history/concomitant medications?:no were pre-existing adhesions noted during the procedure?:not reported how were the post-procedural adhesions confirmed?:with reoperation what is the location and severity of the adhesions?:only the part of interceed used was adhered.Please describe any surgical intervention required including the date and results.The patient was discharged at 10 days after initial surgery, but one week after the discharge, the patient was readmitted to the hospital because of poor food passage.Then, reoperation was performed due to suspected bowel obstruction.Was meticulous hemostasis performed prior to use of product?:unk.What color was the interceed prior to closure?:unk.Did the interceed come in contact with heme prior to use?:yes how was the product applied?: one layer?: wadded?:unk.What suture was used to close the incision?:unk.Was there excessive tissue desiccation (cautery use) at the site of interceed application?:no.What is the physician¿s opinion as to the etiology of or contributing factors to this event?:since the area where interceed was used was clearly adhered, i cannot help but suspect that interceed caused some kind of biological reaction that caused the intestines to adhere.What is the patient's current status?: the patient was already discharged from the hospital and returned to society.Product lot number?:unk.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE INTERCEED 5INX6IN
Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km 8.3
san lorenzo PR 00754
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key18372036
MDR Text Key331094605
Report Number2210968-2023-10015
Device Sequence Number1
Product Code MCN
UDI-Device Identifier10705031147843
UDI-Public10705031147843
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P880047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4350XL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/05/2023
Initial Date FDA Received12/21/2023
Supplement Dates Manufacturer Received12/28/2023
Supplement Dates FDA Received01/16/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-